Literature DB >> 19136771

IgA nephropathy in Kerala, India: a retrospective study.

B Kumari Chandrika1.   

Abstract

This study was conducted to assess the prevalence of IgA nephropathy in Kerala. No published data are available in literature from this part of India. This study included 1592 renal biopsies received from all parts of Kerala over a 2-year period. The age of the subjects ranged from 5 to 78 years old with a peak incidence in the third decade of life. The male:female ratio was 1.2:1. A total of 60% of the cases had presented with hematuria. Direct immunoflourescence was performed using specific antibodies for IgA, IgG, IgM, C3 and C1q. Light microscopic studies with special stains namely PAS, silver and trichrome were also done. A total of 227 cases (14.26% of all renal biopsies) were diagnosed as IgA excluding 12 cases of Henoch-Schonlein Purpura (12.74% in the first year and 15.52% in the second year). The prevalence of IgA nephropathy appears to be increasing in Kerala.

Entities:  

Mesh:

Year:  2009        PMID: 19136771     DOI: 10.4103/0377-4929.44954

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  8 in total

1.  Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction.

Authors:  R W Minz; A Bakshi; S Chhabra; K Joshi; V Sakhuja
Journal:  Indian J Nephrol       Date:  2010-01

2.  Correlates of hematuria on glomerular histology and electron microscopy in IgA nephropathy.

Authors:  Rohit Tewari; Ritambhra Nada; Maninder Kaur; Puja Dudeja; Charan Singh Rayat; Vinay Sakhuja; Kusum Joshi
Journal:  Med J Armed Forces India       Date:  2016-03-29

3.  The Utility of Assessing CD68+ Glomerular Macrophages in Assessing Endocapillary Hypercellularity in IgA Nephropathy.

Authors:  Neha Agrawal; Swarnalata Gowrishankar
Journal:  Indian J Nephrol       Date:  2021-01-27

Review 4.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

5.  Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.

Authors:  Soumita Bagchi; Raghavendra Lingaiah; Kalaivani Mani; Adarsh Barwad; Geetika Singh; Veena Balooni; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

6.  Indian scenario of IgA nephropathy: a systematic review and meta-analysis.

Authors:  Anju Khairwa
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

7.  Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients.

Authors:  Hamid Nasri; Yahya Madihi; Alireza Merrikhi; Allaleh Gheissari; Azar Baradaran; Soleiman Kheiri; Mahmoud Rafieian-Kopaei
Journal:  Int J Prev Med       Date:  2013-05

8.  Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort.

Authors:  Suceena Alexander; George T John; Anila Korula; T S Vijayakumar; Vinoi George David; Anjali Mohapatra; Anna T Valson; Shibu Jacob; Pradeep Mathew Koshy; Gautam Rajan; Elenjickal Elias John; Smita Mary Matthai; L Jeyaseelan; Babu Ponnusamy; Terence Cook; Charles Pusey; Mohamed R Daha; John Feehally; Jonathan Barratt; Santosh Varughese
Journal:  Wellcome Open Res       Date:  2018-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.